1211 related articles for article (PubMed ID: 26237422)
1. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.
Espinar MJ; Miranda IM; Costa-de-Oliveira S; Rocha R; Rodrigues AG; Pina-Vaz C
PLoS One; 2015; 10(8):e0134737. PubMed ID: 26237422
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
3. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
Aris P; Boroumand MA; Rahbar M; Douraghi M
Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
[TBL] [Abstract][Full Text] [Related]
4. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
Martinez P; Garzón D; Mattar S
Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
[TBL] [Abstract][Full Text] [Related]
5. Extended-spectrum beta-lactamase
Vachvanichsanong P; McNeil EB; Dissaneewate P
Epidemiol Infect; 2020 Dec; 149():e12. PubMed ID: 33327984
[TBL] [Abstract][Full Text] [Related]
6. Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors.
Goyal A; Prasad KN; Prasad A; Gupta S; Ghoshal U; Ayyagari A
Indian J Med Res; 2009 Jun; 129(6):695-700. PubMed ID: 19692752
[TBL] [Abstract][Full Text] [Related]
7. Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and empiric therapy.
Uyar Aksu N; Ekinci Z; Dündar D; Baydemir C
Pediatr Int; 2017 Feb; 59(2):176-180. PubMed ID: 27501161
[TBL] [Abstract][Full Text] [Related]
8. Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients.
Pinheiro HS; Mituiassu AM; Carminatti M; Braga AM; Bastos MG
Transplant Proc; 2010 Mar; 42(2):486-7. PubMed ID: 20304172
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Titelman E; Iversen A; Kalin M; Giske CG
Microb Drug Resist; 2012 Apr; 18(2):189-92. PubMed ID: 22204597
[TBL] [Abstract][Full Text] [Related]
10. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
11. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
Brizendine KD; Richter SS; Cober ED; van Duin D
Antimicrob Agents Chemother; 2015 Jan; 59(1):553-7. PubMed ID: 25385105
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
14. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections.
Jansåker F; Frimodt-Møller N; Sjögren I; Dahl Knudsen J
J Antimicrob Chemother; 2014 Mar; 69(3):769-72. PubMed ID: 24107388
[TBL] [Abstract][Full Text] [Related]
15. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Han SB; Lee SC; Lee SY; Jeong DC; Kang JH
BMC Infect Dis; 2015 Oct; 15():414. PubMed ID: 26464143
[TBL] [Abstract][Full Text] [Related]
16. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
Demonchy E; Courjon J; Ughetto E; Durand M; Risso K; Garraffo R; Roger PM
Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.
Søraas A; Sundsfjord A; Sandven I; Brunborg C; Jenum PA
PLoS One; 2013; 8(7):e69581. PubMed ID: 23936052
[TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.
Liao K; Chen Y; Wang M; Guo P; Yang Q; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Xu Y
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):45-48. PubMed ID: 27773544
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children.
Kizilca O; Siraneci R; Yilmaz A; Hatipoglu N; Ozturk E; Kiyak A; Ozkok D
Pediatr Int; 2012 Dec; 54(6):858-62. PubMed ID: 22882781
[TBL] [Abstract][Full Text] [Related]
20. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
